Drugplain

VISTOGARD 951 mg/g

uridine triacetate · GRANULE · BTG International Inc

No Recall History
Plain English

VISTOGARD is a granule containing uridine triacetate at 951 mg/g, taken oral. Manufactured by BTG International Inc.

Key Facts

Brand Name
VISTOGARD
Generic Name
uridine triacetate
NDC Code (Product)
50633-220
Manufacturer
BTG International Inc
Strength
951 mg/g
Dosage Form
GRANULE
Route
ORAL
Marketing Status
Application #
NDA208159
Marketing Start
07/31/2024

Recall History

No Recall History

Frequently Asked Questions

What is VISTOGARD used for?

VISTOGARD contains uridine triacetate. It is a granule taken oral. Consult your doctor for specific uses.

Is VISTOGARD a controlled substance?

VISTOGARD is not classified as a controlled substance by the DEA.

What is the generic name for VISTOGARD?

The generic name for VISTOGARD is uridine triacetate. There are 1 other brand versions of uridine triacetate.

What is the NDC code for VISTOGARD 951 mg/g?

The NDC (National Drug Code) for VISTOGARD 951 mg/g is 50633-220, listed by BTG International Inc.

Product NDC

50633-220

Package NDC

50633-220-04

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)